ArticleImmunology letters2022

Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies.

José Javier Morales-Núñez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.